Open access · CC-BY
via OpenAlex
Emerging pathological mechanisms of Alzheimer’s disease pathogenesis: from neuroimmune interactions to intercellular communication
Rutong Wang, Yingqi Feng, Ziyu Zhou, Jiajun Jiang, Runze Zhang, Wenhui Zou, Haotian Yang, Wenbo Lv, Yang Shen
Frontiers in Aging Neuroscience · 2026 · ▲ 2 citations
Abstract
Alzheimer's disease (AD) research has transcended the traditional paradigm centered on amyloid-beta (Aβ) shifting toward a neuroimmune network perspective. This article systematically elucidates the evolving mechanisms underlying disease progression, from neuroimmune interactions to intercellular communication. Studies indicate that microglial and astrocytic dysfunctions are key contributors to disease progression, operating within a complex multifactorial framework. Upon transformation into disease-associated microglia (DAM), microglia exhibit a significant decline in Aβ clearance capacity and release a plethora of pro-inflammatory factors, exacerbating neuroinflammation and neuronal damage. Concurrently, astrocytes lose their homeostatic support functions and acquire neurotoxic properties. Intercellular communication molecules play pivotal roles as key mediators. The cytokine/chemokine network sustains a chronic inflammatory milieu; extracellular vesicles (EVs) facilitate the propagation of Aβ and tau pathologies; and the complement system (e.g., C1q) transitions from physiological synaptic pruning to pathological synaptic engulfment. Furthermore, peripheral immune cell infiltration and gut-brain axis dysregulation further expand the pathological scope. Consequently, therapeutic strategies are evolving towards multi-target interventions, including precise immune modulation (e.g., TREM2 agonists), exosome-based drug delivery systems, and combination therapies. Addressing disease heterogeneity and developing personalized treatments are critical future directions. Ultimately, early interventions aimed at restoring healthy intercellular communication offer new hope for halting AD progression.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3389/fnagi.2026.1748418
- Canonical
- link ↗
- Fetched
- 2026-11-07 MST
Cite this
APA
Wang, R., Feng, Y., Zhou, Z., Jiang, J., Zhang, R., Zou, W., Yang, H., Lv, W., & Shen, Y. (2026). Emerging pathological mechanisms of Alzheimer’s disease pathogenesis: from neuroimmune interactions to intercellular communication. <em>Frontiers in Aging Neuroscience</em>. https://doi.org/10.3389/fnagi.2026.1748418
Vancouver
Wang R, Feng Y, Zhou Z, Jiang J, Zhang R, Zou W, et al. Emerging pathological mechanisms of Alzheimer’s disease pathogenesis: from neuroimmune interactions to intercellular communication. Frontiers in Aging Neuroscience. 2026. doi:10.3389/fnagi.2026.1748418.
BibTeX
@article{rutong2026Emergi,
title = {Emerging pathological mechanisms of Alzheimer’s disease pathogenesis: from neuroimmune interactions to intercellular communication},
author = {Rutong Wang and Yingqi Feng and Ziyu Zhou and Jiajun Jiang and Runze Zhang and Wenhui Zou and Haotian Yang and Wenbo Lv and Yang Shen},
journal = {Frontiers in Aging Neuroscience},
year = {2026},
doi = {10.3389/fnagi.2026.1748418},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Frontiers in neuroscience
Open access · OA
The Gut-Brain Homeostatic Continuum in Alzheimer’s disease: a systems framework for physiological resilience and disease progression
Nutrients 2023
Open access · CC-BY
Black Goji Berry (Lycium ruthenicum Murray): A Review of Its Pharmacological Activity
Frontiers in neuroscience 2026
Open access · OA
The Gut-Brain Homeostatic Continuum in Alzheimer's disease: a systems framework for physiological resilience and disease progression.
Cells 2024
Open access · CC-BY
Epigenetic Changes in Alzheimer’s Disease: DNA Methylation and Histone Modification
Pharmaceutics 2024
Open access · CC-BY
Extracellular Vesicles in Breast Cancer: From Intercellular Communication to Therapeutic Opportunities
Future Pharmacology 2025
Open access · CC-BY